1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2024, Issue 3
  5. Article
Volume 2024, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Patients with peripheral neuropathy could have damaged peripheral nerves, which leads to sensory and motor dysfunction. Diabetes, infections, and trauma are the major causes of peripheral neuropathy. Vibratory perception threshold (VPT) tools are commonly used to detect peripheral neuropathy. This study aims to determine the assessment of peripheral neuropathy through the different diagnostic tools in the community in Malaysia. A total number of 1283 participants were recruited from the seven retail pharmacies located in Selangor, Malaysia. The peripheral neuropathy test was conducted based on VPT tools on both feet using the digital biothesiometer. Following that, Neurological Symptom Score (NSS) and Neurological Disability Score (NDS) were taken from the participants to assess the neurological symptoms. Participants had an average age of 40.6 ± 12.9 years and were mostly of Chinese ethnicity (54.1%). The findings show that increasing age was associated with more severe peripheral neuropathy across the various assessment tools, but gender differences were found with the biothesiometer test and ethnicity has severity in the biothesiometer and disability scores. The sensitivity and specificity of the biothesiometer test were 0.63 and 0.84, respectively. The combined tool NSS and NDS had high specificity and a high positive predictive value, suggesting that it could be a reliable indicator of peripheral neuropathy when both scores are elevated. The findings show that the biothesiometer test, NSS, and NDS are considered screening VPT tools for diagnosing peripheral neuropathy. However, further evaluation and diagnostic testing are necessary in cases of a positive test result.

© 2024 Mooi, Lee, Yusof Khan, Devaraj, Cheong, Hoo et al., Licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2024.24
2024-08-06
2024-09-26
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/3/qmj.2024.24.html?itemId=/content/journals/10.5339/qmj.2024.24&mimeType=html&fmt=ahah

References

  1. Hanewinckel R, Ikram MA, Van Doorn PA. Peripheral neuropathies. Handb Clin Neurol. 2016; 138:263–82. https://doi.org/10.1016/B978-0-12-802973-2.00015-X
     [Google Scholar]
  2. Edmonds M, Manu C, Vas P. The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021; 17:88–93. https://doi.org/10.1016/j.jcot.2021.01.017
     [Google Scholar]
  3. Petropoulos IN, Ponirakis G, Khan A, Almuhannadi H, Gad H, Malik RA. Diagnosing diabetic neuropathy: Something old, something new. Diabetes Metab J. 2018; 42:(4):255–69. https://doi.org/10.4093/dmj.2018.0056
     [Google Scholar]
  4. Carmichael J, Fadavi H, Ishibashi F, Shore AC, Tavakoli M. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol (Lausanne). 2021; 12:671257. https://doi.org/10.3389/fendo.2021.671257
     [Google Scholar]
  5. Sharma KNS, Kumar HA. Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy. J Foot Ankle Res. 2023; 16:(1):65. https://doi.org/10.1186/s13047-023-00667-3.
    [Google Scholar]
  6. Barrell K, Smith AG. Peripheral neuropathy. Med Clin N Am. 2019; 103:(2):383–97. https://doi.org/10.1016/j.mcna.2018.10.006
     [Google Scholar]
  7. Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, et al.. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res. 2011; 133:(6):645–9.
    [Google Scholar]
  8. Chawla A, Bhasin G, Chawla R. Validation of neuropathy symptoms score (NSS) and neuropathy disability score (NDS) in the clinical diagnosis of peripheral neuropathy in middle aged people with diabetes. Internet J Fam Pract. 2013; 12:(1):1–4.
    [Google Scholar]
  9. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001; 24:(2):250–6. https://doi.org/10.2337/diacare.24.2.250
     [Google Scholar]
  10. Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, et al.. Scoring systems to screen for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2018 (7):CD010974.
    [Google Scholar]
  11. Abougalambou SSI, Abougalambou AS. Explorative study on diabetes neuropathy among type II diabetic patients in Universiti Sains Malaysia Hospital. Diabetes Metab Syndr. 2012; 6:(3):167–72. https://doi.org/10.1016/j.dsx.2012.09.002
     [Google Scholar]
  12. Fatimah AB, Aziz NA, Amaramalar SN, Aznida FAA, Hamid MZA, Norlaila M. Risk determinants of peripheral neuropathy in patients with type ii diabetes mellitus attending follow-up clinics at Universiti Kebangsaan Malaysia Medical Center (UKMMC): A cross-sectional study. Med & Health. 2010; 5:(1):34–40.
    [Google Scholar]
  13. Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia. 2003; 58:(4):533–8.
    [Google Scholar]
  14. Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology. 1991; 41:(8):1315–7. https://doi.org/10.1212/wnl.41.8.1315
     [Google Scholar]
  15. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993; 36:(2):150–4. https://doi.org/10.1007/BF00400697
     [Google Scholar]
  16. Yu Y. Gold standard for diagnosis of DPN. Front. Endocrinol (Lausanne). 2021; 12:719356. https://doi.org/10.3389/fendo.2021.719356
     [Google Scholar]
  17. Adeleye OO, Ogbera AO, Fasanmade O, Ogunleye OO, Dada AO, Ale AO, et al.. Latent Autoimmune Diabetes Mellitus in Adults (LADA) and it’s characteristics in a subset of Nigerians initially managed for type 2 diabetes. Int Arch Med. 2012; 5:(1):23. https://doi.org/10.1186/1755-7682-5-23
     [Google Scholar]
  18. SPSS I. IBM SPSS statistics for Windows. Armonk, New York, USA: IBM SPSS;2013p. 119.
    [Google Scholar]
  19. Mao F, Zhu X, Liu S, Qiao X, Zheng H, Lu B, et al.. Age as an independent risk factor for diabetic peripheral neuropathy in Chinese patients with type 2 diabetes. Aging Dis. 2019; 10:(3):592. https://doi.org/10.14336/AD.2018.0618
     [Google Scholar]
  20. Zografou I, Iliadis F, Sambanis C, Didangelos T. Validation of neuropad in the assessment of peripheral diabetic neuropathy in patients with diabetes mellitus versus the Michigan neuropathy screening instrument, 10g monofilament application and biothesiometer measurement. Curr Vasc Pharmacol. 2020; 18:(5):517–22. https://doi.org/10.2174/1570161117666190723155324
     [Google Scholar]
  21. Yawn BP, Wollan PC, Weingarten TN, Watson JC, Hooten WM, Melton 3rd LJ. The prevalence of neuropathic pain: Clinical evaluation compared with screening tools in a community population. Pain Med. 2009; 10:(3):586–93. https://doi.org/10.1111/j.1526-4637.2009.00588.x
     [Google Scholar]
  22. Karki D, Nagila A, Dhakal N, Chhetri S. Prevalence of peripheral neuropathy in diabetes mellitus and its association with therapy, ethnicity and duration of diabetes mellitus. J Med Sci. 2018; 10:(1):72–6.
    [Google Scholar]
  23. Pourhamidi K, Dahlin LB, Englund E, Rolandsson O. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy. Prim Care Diabetes. 2014; 8:(1):77–84. https://doi.org/10.1016/j.pcd.2013.04.004
     [Google Scholar]
  24. Arshad AR, Alvi KY. Diagnostic accuracy of clinical methods for detection of diabetic sensory neuropathy. J Coll Physicians Surg Pak. 2016; 26:(5):374–9.
    [Google Scholar]
  25. Kamel SR, Hamdy M, Abo Omar HA, Kamal A, Ali LH, Abd Elkarim AH. Clinical diagnosis of distal diabetic polyneuropathy using neurological examination scores: Correlation with nerve conduction studies. Egypt Rheumatol Rehabil. 2015;42:128–36. https://doi.org/10.4103/1110-161X.163945
     [Google Scholar]
  26. Williams RH, Kronenberg H. Williams textbook of endocrinology. Philadelphia, PA: Saunders;2007.
    [Google Scholar]
/content/journals/10.5339/qmj.2024.24
Loading
Using biothesiometer, Neuropathy Symptom Score, and Neuropathy Disability Score for the early detection of peripheral neuropathy: A cross-sectional study
Qatar Medical Journal 2024, 24 (2024); https://doi.org/10.5339/qmj.2024.24
/content/journals/10.5339/qmj.2024.24
/content/journals/10.5339/qmj.2024.24
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): biothesiometer, Peripheral neuropathy and sensitivity and specificity

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error